Skip to main content
logo
Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
2.000
0.00 (0.00%)
At close: Dec 31, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2007 - 2019
Drug and Peptide
804.23K
Log In
Log In
Log In
Log In
Upgrade
Drug and Peptide Growth
-19.39%
Log In
Log In
Log In
Log In
Upgrade
Licensing Fees
-
Log In
Log In
Log In
Log In
Upgrade
Licensing Fees Growth
-
Log In
Log In
Log In
Log In
Upgrade
Peptide and Consumer Product
-
Log In
Log In
Log In
Log In
Upgrade
Peptide and Consumer Product Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2007 - 2019
United States
804.23K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-19.39%
Log In
Log In
Log In
Log In
Upgrade